Orbita will launch an add-on for the Amazon Echo to enable it to act as a personal assistant for people with chronic conditions and streamline the work of healthcare agents. But in the interview, he declined to name the organization because the formal launch is not until Oct. 7. To be released on 7 October, the company will begin operating “lower risk applications” first, meaning that monitoring and confirmation of medication dosages will not be immediately available. The new app is designed specifically for patients who are at high risk, such as those suffering from cancer, multiple sclerosis or diabetes.
Orbita will launch an add-on for the Amazon Echo to enable it to act as a personal assistant for people with chronic conditions and streamline the work of healthcare agents. To be released on 7 October, the company will begin operating “lower risk applications” first, meaning that monitoring and confirmation of medication dosages will not be immediately available. The new app is designed specifically for patients who are at high risk, such as those suffering from cancer, multiple sclerosis or diabetes.